AMGEN to open new site in Hyderabad

Amgen India Will Accelerate Innovation and Digital Capabilities Across Amgen’s Global Organization

Amgen (NASDAQ:AMGN) today announced plans to open a new technology and innovation site in Hyderabad, India. The site, known as Amgen India, will accelerate digital capabilities across the global organization to further advance Amgen’s pipeline of medicines.

Amgen India will be located in HITEC City, a suburb of Hyderabad, occupying six floors in Hitech City, Hyderabad. The city of Hyderabad, located in the state of Telangana, was selected for its world-class talent across medicine, life sciences and data sciences and the rapidly advancing field of artificial intelligence (AI). The site can accommodate up to 3,000 people and will be operational in Q4 2024.

“At a time when a quickly aging global population needs more innovation, the convergence of biotechnology and technology is enabling Amgen to work with greater speed, confidence, and efficiency — _an incredibly exciting milestone for which we have been preparing for over a decade,” said David M Reese, M.D., executive vice president and chief technology officer at Amgen. “Amgen has been a leader in biotechnology for over 40 years and establishing this new site in India, a country known for its world-class technology and life sciences talent, marks a significant step forward in our journey to deliver on our mission to serve patients.”

Amgen India will initially build and accelerate new technology solutions and digital capabilities at scale that will enhance efficiencies across the enterprise. The site will offer roles that strengthen key areas of Amgen’s business, including AI, data science, life science and other additional global capabilities over time.
To lead Amgen’s expanded presence in India, Som Chattopadhyay has been appointed national executive for India.

Chief Minister A. Revanth Reddy said, “it is a great breakthrough and a matter of pride for us to have one of the world’s largest biotech firms choose Hyderabad for its first development facilities in Telangana.”

“Amgen’s new site in Hyderabad underscores the city’s position as a hub for innovation and technology,” he added. “We are proud to welcome a global trailblazer of the biotechnology industry. Amgen’s unwavering mission to serve patients will be incredibly inspiring for the world-class technology talent seeking to make a meaningful impact on people around the world.”

Chief Minister Sri Anumula Revanth Reddy and Industries Minister Sri Duddilla Sridhar Babu met Dr. David Reese and Mr. Som Chattopadhyay at Amgen’s R&D site in San Francisco today.

Speaking after the meeting, Minister for Industries Sri Duddilla Sridhar Babu said, “I’m thrilled to note that Amgen has chosen Hyderabad to establish Amgen India. This development is a powerful endorsement of the world-class life sciences ecosystem we’re cultivating in Telangana. The government is committed to partnering with Amgen to ensure their success here. This marks the beginning of a promising, long-term collaboration, and we’re excited about the healthier future we’re building together!“

Amgen has nearly 27,000 employees and has a presence in approximately 100 countries and regions worldwide, including India.